Bio-Techne Financials - Benzinga

Bio-Techne Corp

TECHNASDAQ

Trade with Public

Trade with Public

$72.61

0.040.06%

가까이에: Sep 25, 5:00 PM EST

$72.61

N/A

시간외: 4:00 PM EST

개요 뉴스 실적 전망 이벤트 목표가재무심리 지분 현황 배당금 비교 옵션 주식 보고서

Bio-Techne Financials

Bio-Techne (TECH) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Bio-Techne Q4 Adj. EPS $0.52, Inline, Sales $321.191M Beat $314.679M Estimate

Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.52 per share which met the analyst consensus estimate. This is a 1.89 percent decrease over earnings of $0.53 per share from the same period last year. The

Benzinga Newsdesk

Earnings Scheduled For May 6, 2026

Benzinga Insights

PRO
Bio-Techne Q3 Adj. EPS $0.53 Misses $0.54 Estimate, Sales $311.415M Miss $317.093M Estimate

Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.53 per share which missed the analyst consensus estimate of $0.54 by 1.85 percent. This is a 5.36 percent decrease over earnings of $0.56 per share from the same

Benzinga Newsdesk

Insights into Bio-Techne Q2 Earnings

Benzinga Insights

Bio-Techne Earnings Review: Q2 Summary

Benzinga Insights

Earnings Breakdown: Bio-Techne Q2

Benzinga Insights

© 2026 Benzinga | All Rights Reserved